CML is a malignant hematopoietic disorder characterized by a reciprocal chromosomal translocation, t(9;22)(q34;q11.2), which results in the formation of the BCR::ABL1 fusion gene. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.